Author Archives: Shane Whitney

RAAS Activation and Renal Hemodynamic Function in Type 1 Diabetes Mellitus

There has been a decline in the rates of advanced chronic kidney disease (including end-stage renal disease) in patients with type 1 diabetes mellitus (T1DM); however, diabetic nephropathy remains relatively common. In patients with T1DM without diabetic nephropathy, the 20-year mortality risk is comparable to that of the general population, while the presence of diabetic nephropathy is associated with a ... Read More »

Cost-Effectiveness of Pneumococcal Vaccination among Patients Age 50 to 64 with CKD

Due to high morbidity and mortality risk, pneumococcal disease is a major public health concern. Vaccination against Streptococcus pneumoniae reduces the risk for pneumococcal disease by 30% to 50%, according to results of earlier studies. The vaccine is recommended by the Advisory Committee on Immunization Practices (ACIP) of the US Centers for Disease Control and Prevention for all adults ≥65 ... Read More »

New Physical Activity Questionnaire Validated among Dialysis Patients

Patients with end-stage renal disease (ESRD) are often extremely sedentary. In a previous study that included healthy age-matched controls who reported no participation in regular physical activity, patients on maintenance hemodialysis were , on average, 35% less active over a 1-week period. Several large prospective cohort studies found an association between physical inactivity and higher mortality patients on hemodialysis and ... Read More »

Cancer Incidence Higher in Patients with CKD

Boston—In the United States, cancer is a leading cause of morbidity and mortality. Further, an estimated one in three Americans is at risk for chronic kidney disease (CKD). There are data from previous studies on the risk of certain cancers in patients on dialysis; however, studies on the incidence of cancer in patients with CKD are limited. Jagadeesh Puvvula, PharmD, ... Read More »

Outcomes in Renal Cell Carcinoma with Brain Metastases

In patients with metastatic renal cell carcinoma (mRCC), there has been an association between brain metastases and poor prognosis. I. Alex Bowman, MD, and colleagues at the University of Texas Southwestern Medical Center, have previously reported improved outcomes for RCC patients with brain metastases prior to or during first line therapy among patients treated with modern systemic and local therapies. ... Read More »

October 2019: Abstract Round Up

ACUTE KIDNEY INJURY Effects of Acute Kidney Injury on Urinary Protein Excretion Journal of the American Society of Nephrology. 2019;30(7):1271-1281 There are few available data on the potential effects of acute kidney injury (AKI) on proteinuria, despite the fact that proteinuria is a strong risk factor for future loss of renal function. Researchers, led by Chi-yuan Hsu, MD, MS, conducted ... Read More »

October 2019 News Briefs

AMA Grants CPT-PLA Code for KidneyIntelX™ The American Medical Association (AMA) has granted a CPT® (Current Procedural Terminology) Proprietary Laboratory Analyses (PLA) Code for KidneyIntelX™, the lead product from RenalytixAI. The new code, 0105U, has been approved and published by the AMA CPT Editorial Panel, effective October 1, 2019. According to a press release from RenalytixAI, a payment rate for ... Read More »

From the Field: Monthly Capitation Payment Breakdown

By Sarah Tolson In recent months, I’ve received an influx of questions from readers about the Medicare Monthly Capitation Payment (MCP). Many of these questions are related to the increasing utilization of physician assistants (PAs) and nurse practitioners (NPs), in addition to questions about CMS regulation changes at the beginning of the year that allow free-standing dialysis facilities and patient ... Read More »

From the Chair: Dialysis Moonshot Revisited: Options for the Elderly

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital Harvard Medical School In a previous editorial, I made the case for the federal government funding a Dialysis Moonshot initiative, set up similarly to the Obama administration’s Cancer Moonshot that was spearheaded by Vice President Joe Biden. In occasional articles, I intend to cover areas of dialysis care where research ... Read More »